keine Finanzberatung

VEEV · Veeva Systems

Cloud software for pharma and life-sciences companies

Risiko 5/10 · MODERATE RISK · life-sciences cloud priced for perfection · $275.09 ▼ 3.27%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $275.09
  • Market cap $44.5B
  • P/E (ttm) 45.02
  • Div yield none
  • 52-wk range $148.05 – $310.50
  • Index rank #348 / —

Wichtigste Risiken

  • Valuation leaves no room for a growth stumble (Shareholders) — HIGH
  • Salesforce turning from partner to rival after the platform split (Shareholders) — MED
  • Pharma budget cuts hitting seat counts and renewals (Shareholders) — MED
  • Concentration in a single vertical (Shareholders) — MED

Fazit

Exceptional niche business, unexceptional entry price — buy the moat only if you can stomach the multiple.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.